ATPW
CVS icon

Ashton Thomas Private Wealth’s CVS Health CVS Stock Holding History

Ashton Thomas Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
25,988
+2,463
+10% +$220K 0.06% 326
2026
Q1 		$1.69M Buy
23,525
+5,187
+28% +$400K 0.04% 403
2025
Q4 		$1.46M Buy
18,338
+5,861
+47% +$462K 0.04% 392
2025
Q3 		$941K Buy
12,477
+39
+0.3% +$2.67K 0.02% 481
2025
Q2 		$858K Buy
12,438
+3,057
+33% +$200K 0.03% 453
2025
Q1 		$636K Buy
9,381
+1,615
+21% +$96.6K 0.02% 493
2024
Q4 		$349K Sell
7,766
-8,483
-52% -$476K 0.01% 601
2024
Q3 		$1.02M Sell
16,249
-6,132
-27% -$358K 0.05% 307
2024
Q2 		$1.32M Sell
22,381
-10,857
-33% -$679K 0.07% 260
2024
Q1 		$2.65M Sell
33,238
-1,997
-6% -$153K 0.15% 168
2023
Q4 		$2.78M Sell
35,235
-2,348
-6% -$167K 0.17% 156
2023
Q3 		$2.62M Buy
37,583
+347
+0.9% +$24.6K 0.19% 145
2023
Q2 		$2.57M Sell
37,236
-6,345
-15% -$451K 0.2% 140
2023
Q1 		$3.24M Buy
43,581
+8,574
+24% +$719K 0.28% 94
2022
Q4 		$3.26M Sell
35,007
-8,884
-20% -$857K 0.32% 83
2022
Q3 		$4.19M Buy
43,891
+1,507
+4% +$149K 0.47% 47
2022
Q2 		$3.93M Buy
42,384
+11,240
+36% +$1.1M 0.42% 61
2022
Q1 		$3.15M Buy
31,144
+6,334
+26% +$665K 0.28% 100
2021
Q4 		$2.56M Sell
24,810
-4,198
-14% -$388K 0.25% 104
2021
Q3 		$2.46M Buy
29,008
+3,068
+12% +$257K 0.36% 72
2021
Q2 		$2.16M Buy
25,940
+494
+2% +$40.5K 0.33% 81
2021
Q1 		$1.91M Sell
25,446
-147
-0.6% -$10.7K 0.32% 77
2020
Q4 		$1.75M Buy
25,593
+964
+4% +$62.7K 0.33% 81
2020
Q3 		$1.44M Buy
24,629
+10,901
+79% +$678K 0.36% 74
2020
Q2 		$892K Sell
13,728
-57
-0.4% -$3.59K 0.26% 101
2020
Q1 		$818K Buy
13,785
+1,828
+15% +$122K 0.33% 87
2019
Q4 		$888K Buy
+11,957
New +$840K 0.29% 94

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ashton Thomas Private Wealth's CVS Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its CVS Health (CVS) stake by 10% in Q2 2026, buying an estimated $220K and bringing the position to 25,988 shares worth $2.69M. The position accounts for 0.06% of the portfolio, ranked #326.

Ashton Thomas Private Wealth first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.19M in Q3 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ashton Thomas Private Wealth held 25,988 shares of CVS Health worth $2.69M as of Q2 2026.
  • Ashton Thomas Private Wealth bought 2,463 CVS Health shares in Q2 2026, an estimated $220K.
  • CVS Health made up 0.06% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #326 holding.
  • Ashton Thomas Private Wealth first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Ashton Thomas Private Wealth's CVS Health position peaked at $4.19M in Q3 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.